Study information:
A trial of Exenatide for the treatment of moderate severity Parkinson's disease

Condition category
Nervous System Diseases
Date applied:
24/01/2014

Date assigned
24/01/2014


Overall trial status
Ongoing

Recruitment status
No longer recruiting

Where is the study run from?
The study is being co-ordinated by University College London Clinical Trials Unit. Patients will have an appointment at the National Hospital for Neurology and Neurosurgery - part of University College London Hospitals.

When is the study starting and how long is it expected to run for?
The study will start in June 2014 and end in June 2016. Patient recruitment will finalise in March 2015.

Who is funding the study?
This research is being funded by the Michael J Fox Foundation for Parkinson's Research and the drug is being provided free of charge by Bristol-Myers Squibb/AstraZeneca.
http://www.isrctn.com/ISRCTN75891427